Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Immunocore Holdings Plc ADR (NQ: IMCR )

55.35 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 55.35
Bid (Size) 24.88 (5)
Ask (Size) 65.00 (1)
Prev. Close 55.35
Today's Range 55.35 - 55.35
52wk Range 26.12 - 69.06
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Immunocore presents additional ctDNA data from the KIMMTRAK Phase 3 trial at ASCO
From Immunocore Holdings Limited
Via GlobeNewswire
Immunocore to present at upcoming investor conferences
From Immunocore Holdings Limited
Via GlobeNewswire

Performance

YTD
-0.13%
-0.13%
1 Month
-7.55%
-7.55%
3 Month
+4.02%
+4.02%
6 Month
-13.16%
-13.16%
1 Year
+59.28%
+59.28%

More News

Read More
Expert Ratings for Immunocore Hldgs
Via Benzinga
Recap: Immunocore Hldgs Q1 Earnings
Via Benzinga
Immunocore Reports First Quarter 2023 Financial Results and Provides Business Update
From Immunocore Holdings Limited
Via GlobeNewswire
Analyst Ratings for Immunocore Hldgs
Via Benzinga
Earnings Scheduled For March 1, 2023
Via Benzinga
Preview: Immunocore Holdings's Earnings
Via Benzinga
Immunocore Reveals First Data From HIV Infection Candidate Study
Via Benzinga
Immunocore to present at the Bank of America Securities 2023 Health Care Conference
From Immunocore Holdings Limited
Via GlobeNewswire
Immunocore presents new KIMMTRAK data confirming association between early ctDNA reduction and longer overall survival
From Immunocore Holdings Limited
Via GlobeNewswire
Short Volatility Alert: Immunocore Hldgs
Via Benzinga
Immunocore to present at the 22nd Annual Needham Virtual Healthcare Conference
From Immunocore Holdings Limited
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2023
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Immunocore to present four posters at AACR Annual Meeting 2023
From Immunocore Holdings Limited
Via GlobeNewswire
Immunocore Reports 2022 Financial Results and Provides Business Update
From Immunocore Holdings Limited
Via GlobeNewswire
Immunocore to present at upcoming investor conferences
From Immunocore Holdings Limited
Via GlobeNewswire
Immunocore to Report Fourth Quarter and Full Year 2022 Earnings and Host Call on March 1, 2023
From Immunocore Holdings Limited
Via GlobeNewswire
Immunocore announces initial Phase 1 safety and pharmacodynamic activity data with first soluble TCR therapy for people living with HIV
From Immunocore Holdings Limited
Via GlobeNewswire
Biotech's Drug Pipeline Expands From Melanoma To Other Cancers
Via Investor's Business Daily
Is Biotech Immunocore About To Make A 25% Price Move?
Via MarketBeat
Topics ETFs
Immunocore to present at upcoming investor conferences
From Immunocore Holdings Limited
Via GlobeNewswire
3 Pharma Stocks That Will Mint Millionaires
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.